Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Urothelial carcinoma-invasive

Large cell undifferentiated carcinoma

Reviewer: Rugvedita Parakh, M.D. (see Reviewers page)
Revised: 9 February 2013, last major update June 2010
Copyright: (c) 2003-2013, PathologyOutlines.com, Inc.


● Rare poorly differentiated pleomorphic carcinoma that cannot be otherwise classified

Clinical features

● Advanced stage at presentation with nodal metastases
● Poorer survival than urothelial carcinoma NOS of similar stage (Pathology 2010;42:364)

Micro description

● Sheets of large polygonal or round cells with moderate to abundant cytoplasm, distinct cell borders
● Usually 90%+ of tumor is composed of large cell component
● Tumor is either infiltrative or has solid expansile nests with variable dyscohesive growth

Positive stains

● AE1/AE3 and CK7; variable CAM 5.2, CK20, thrombomodulin and uroplakin III
● High Ki-67, p53+

Negative stains

● AFP, beta hCG, PSA, vimentin, synaptophysin and chromogranin

Differential diagnosis

Lymphoma: morphology of lymphoma subtype, negative for keratin, positive for lymphocytic markers
Melanoma: spindled or epithelioid; prominent nucleoli; positive for melanocytic markers

End of Bladder > Urothelial carcinoma-invasive > Large cell undifferentiated carcinoma

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at [email protected] with any questions (click here for other contact information).